Answers are grounded in this paper and cite their sources.
We introduce a novel and versatile microfluidic technology that allows parallel and multi-step bioanalytical procedures to be simply implemented by switching reagent-containing droplet arrays among alternative interaction zones for intended mass or energy transport in a programmable manner. This enables multiplexed complex bioassays for point-of-care testing.
No takes yet. Share an insight, caveat, or question.
Shu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: